0000919574-26-002414.txt : 20260427 0000919574-26-002414.hdr.sgml : 20260427 20260427190817 ACCESSION NUMBER: 0000919574-26-002414 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260423 FILED AS OF DATE: 20260427 DATE AS OF CHANGE: 20260427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BROADWOOD PARTNERS, L.P. CENTRAL INDEX KEY: 0001278386 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37648 FILM NUMBER: 26902654 BUSINESS ADDRESS: STREET 1: BROADWOOD CAPITAL INC. STREET 2: 156 WEST 56TH STREET, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-508-5735 MAIL ADDRESS: STREET 1: BROADWOOD CAPITAL INC. STREET 2: 156 WEST 56TH STREET, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER NAME: FORMER CONFORMED NAME: BROADWOOD PARTNERS LP DATE OF NAME CHANGE: 20040202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BROADWOOD CAPITAL INC CENTRAL INDEX KEY: 0001278387 ORGANIZATION NAME: STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37648 FILM NUMBER: 26902653 BUSINESS ADDRESS: STREET 1: 156 WEST 56TH STREET STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-508-5735 MAIL ADDRESS: STREET 1: 156 WEST 56TH STREET STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bradsher Neal C CENTRAL INDEX KEY: 0001278388 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37648 FILM NUMBER: 26902652 MAIL ADDRESS: STREET 1: 156 WEST 56TH STREET, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER NAME: FORMER CONFORMED NAME: BRADSHER NEAL C DATE OF NAME CHANGE: 20040202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Insight Molecular Diagnostics Inc. CENTRAL INDEX KEY: 0001642380 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences EIN: 271041563 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 INTERNATIONAL PLAZA DR., SUITE 510 CITY: NASHVILLE STATE: TN ZIP: 37217 BUSINESS PHONE: 949-409-7600 MAIL ADDRESS: STREET 1: 2 INTERNATIONAL PLAZA DR., SUITE 510 CITY: NASHVILLE STATE: TN ZIP: 37217 FORMER COMPANY: FORMER CONFORMED NAME: Oncocyte Corp DATE OF NAME CHANGE: 20210920 FORMER COMPANY: FORMER CONFORMED NAME: OncoCyte Corp DATE OF NAME CHANGE: 20200213 FORMER COMPANY: FORMER CONFORMED NAME: Oncocyte Corp DATE OF NAME CHANGE: 20200205 4 1 ownership.xml X0609 4 2026-04-23 0 0001642380 Insight Molecular Diagnostics Inc. IMDX 0001278386 BROADWOOD PARTNERS, L.P. false C/O BROADWOOD CAPITAL INC. 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019 0 0 1 0 0001278387 BROADWOOD CAPITAL INC false 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019 0 0 1 0 0001278388 Bradsher Neal C false C/O BROADWOOD CAPITAL, INC. 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019 0 0 1 0 0 Common Stock, no par value 2026-04-23 4 P 0 280381 3.5025 A 12395081 D Common Stock, no par value 2026-04-23 4 P 0 0 0 A 12395081 I Footnote Common Stock, no par value 2026-04-24 4 P 0 38880 3.5258 A 12433961 D Common Stock, no par value 2026-04-24 4 P 0 0 0 A 12433961 I Footnote Common Stock, no par value 2026-04-27 4 P 0 250923 3.6391 A 12684884 D Common Stock, no par value 2026-04-27 4 P 0 0 0 A 12684884 I Footnote Common Stock, no par value 157 D Warrant to Purchase Common Stock 30.60 2027-04-19 Common Stock 150093 150093 D Warrant to Purchase Common Stock 30.60 2027-04-19 Common Stock 150093 150093 I Footnote The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed to be beneficially owned by each of: (i) Broadwood Capital, Inc. ("Broadwood Capital"), as General Partner of Broadwood Partners; and (ii) Neal C. Bradsher, as President of Broadwood Capital. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. These securities are directly owned by Neal C. Bradsher. This constitutes the weighted average purchase price. The prices range from $3.39 to $3.54. The Reporting Person will provide upon request by the Securities and Exchange Commission staff (the "SEC Staff"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. This constitutes the weighted average purchase price. The prices range from $3.47 to $3.59. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. This constitutes the weighted average purchase price. The prices range from $3.50 to $3.84. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. These warrants are currently exercisable. Broadwood Partners, L.P., By: Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President 2026-04-27 Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President 2026-04-27 Neal C. Bradsher, /s/ Neal C. Bradsher 2026-04-27